Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 22309845 | HLA-B*51 | vasculitides | NA | NA | NA | unclassified | |
| however, they are associated with two different vasculitides (hla-b*51 in behcet's disease and hla-b*52 in takayasu's arteritis (tak)) and with major clinical and immunological differences. | |||||||
| 22309845 | HLA-B*52 | takayasu's arteritis | NA | NA | NA | unclassified | |
| however, they are associated with two different vasculitides (hla-b*51 in behcet's disease and hla-b*52 in takayasu's arteritis (tak)) and with major clinical and immunological differences. | |||||||
| 22309845 | HLA-B*52 | vasculitides | NA | NA | NA | unclassified | |
| however, they are associated with two different vasculitides (hla-b*51 in behcet's disease and hla-b*52 in takayasu's arteritis (tak)) and with major clinical and immunological differences. | |||||||
| 22309845 | HLA-B*51 | takayasus arteritis | NA | NA | NA | negation | |
| takayasu's arteritis is associated with hla-b*52, but not with hla-b*51, in turkey. | |||||||
| 22309845 | HLA-B*52 | takayasus arteritis | NA | NA | NA | negation | |
| takayasu's arteritis is associated with hla-b*52, but not with hla-b*51, in turkey. | |||||||
| 22999907 | HLA-B*27 | takayasu's arteritis | NA | adalimumab | NA | unclassified | |
| here, however, we describe the case of two patients: one with seropositive rheumatoid arthritis, the other with hla-b27 negative spondylarthropathy, who developed takayasu's arteritis during treatment with tnfa inhibitors (adalimumab and golimumab respectively). | |||||||
| 22999907 | HLA-B*27 | rheumatoid arthritis | NA | adalimumab | NA | unclassified | |
| here, however, we describe the case of two patients: one with seropositive rheumatoid arthritis, the other with hla-b27 negative spondylarthropathy, who developed takayasu's arteritis during treatment with tnfa inhibitors (adalimumab and golimumab respectively). | |||||||
| 22999907 | HLA-B*27 | spondylarthropathy | NA | adalimumab | NA | unclassified | |
| here, however, we describe the case of two patients: one with seropositive rheumatoid arthritis, the other with hla-b27 negative spondylarthropathy, who developed takayasu's arteritis during treatment with tnfa inhibitors (adalimumab and golimumab respectively). | |||||||
| 23508490 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | takayasu's arteritis | Korean | NA | NA | positive | |
| the patient was diagnosed with takayasu's arteritis (ta) and had human leukocyte antigen (hla) b-52, which is frequently found in patients having both uc and takayasu's disease concurrently on hla analysis. | |||||||
| 91227 | HLA-A (HLA-A) | thromboangiitis obliterans | NA | NA | NA | unclassified | |
| the incidence of thromboangiitis obliterans in brothers and the high prevalence in some ethnic groups have led us to investigate the histocompatibility hla-a, b and dr antigens of 46 buerger's disease patients. | |||||||
Copyright 2024